Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Romanowska-Prochnicka, Katarzyna
NCT04781543 / 2020-005764-62: A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis Jan 2024 - Dec 2024: Data from trial for diffuse cutaneous systemic sclerosis	Recruiting	2	300	Europe, Japan, US, RoW	HZN-825 BID, Placebo, HZN-825 QD	Amgen	Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic	10/24	09/25
Jeka, Marta
NCT05436652 / 2022-000299-20: A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)	Recruiting	2	72	Europe	SPI-62, SPI-62 matched placebo, Prednisolone 10mg, Additional prednisolone, Additional prednisolone matched placebo	Sparrow Pharmaceuticals	Polymyalgia Rheumatica	04/25	07/25
NCT04781543 / 2020-005764-62: A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis Jan 2024 - Dec 2024: Data from trial for diffuse cutaneous systemic sclerosis	Recruiting	2	300	Europe, Japan, US, RoW	HZN-825 BID, Placebo, HZN-825 QD	Amgen	Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic	10/24	09/25